Velphoro Approval History
- FDA approved: Yes (First approved November 27th, 2013)
- Brand name: Velphoro
- Generic name: sucroferric oxyhydroxide
- Company: Vifor Fresenius Medical Care Renal Pharma
- Treatment for: Hyperphosphatemia of Renal Failure
Velphoro (sucroferric oxyhydroxide) is a chewable, iron-based phosphate binder for the control of serum phosphorus levels in patients with Chronic Kidney Disease (CKD) on dialysis.
Development History and FDA Approval Process for Velphoro
|Nov 30, 2013||Velphoro Receives US FDA Approval for the Treatment of Hyperphosphatemia in Chronic Kidney Disease Patients on Dialysis|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.